Custics Singapore’s HAUTUKI Secures FDA OTC Product Registration and Excels in Skin Sensitivity Testing

Custics Singapore announces that HAUTUKI has achieved a significant milestone by securing registration as an OTC Product with the U.S. FDA

HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered to enhance the delivery of large molecules through the skin, thereby optimizing their absorption and therapeutic impact.

 

A representative from HAUTUKI commented, “Securing FDA OTC registration is a testament to HAUTUKI’s quality and safety. Furthermore, HAUTUKI has successfully passed rigorous skin sensitivity testing with a score of 0, indicating zero irritation. This result underscores our commitment to providing a product that is not only effective but also gentle on the skin.”

 

The representative further stated, “Our goal is to ensure that consumers can purchase HAUTUKI with complete confidence. We are dedicated to maintaining the highest standards of safety and efficacy for our users.”

For more information, visit HAUTUKI's official website.

Distributor Name – Amit Biswas

Distribution Agency Name – Grow With Amit

Distributor Contact Number – 1169312053

Media Contact
Company Name: Grow With Amit
Contact Person: Amit Biswas
Email: Send Email
Country: India
Website: https://www.fiverr.com/grow_withamit


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.